| Trial ID: | L2718 |
| Source ID: | NCT00541229
|
| Associated Drug: |
Sitagliptin Phosphate
|
| Title: |
Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00541229/results
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: sitagliptin phosphate|DRUG: sitagliptin phosphate|DRUG: Comparator: Placebo
|
| Outcome Measures: |
Primary: 24-hour Weighted Mean Glucose (WMG), The 24-hour WMG was calculated as the area under the 24-hour glucose curve (AUC(0-24 hr)) divided by 24 using linear trapezoidal method., Day 7 of Treatment Period I. Due to a carry-over effect that was observed between treatment periods, efficacy results are presented from Treatment Period I only. |
|
| Sponsor/Collaborators: |
Sponsor: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
103
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-08-24
|
| Completion Date: |
2008-07-01
|
| Results First Posted: |
2009-07-28
|
| Last Update Posted: |
2017-05-12
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00541229
|
